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Objective: This study was undertaken to further define the impact of intraoperative
transesophageal echocardiography during surgery for congenital heart disease and to
determine appropriate indications.
Methods: The impact of transesophageal echocardiography on patient care was
assessed in 1002 patients who underwent this procedure during surgery for con-
genital heart defects. It had major impact when new information altered the planned
procedure or led to a revision of the initial repair. The safety of intraoperative
transesophageal echocardiography was evaluated by review of the prospective data
sheets and the medical record. A simple relative cost analysis was also performed.
Results: Patient median age was 9.9 years (range 2 days to 85 years). Transesoph-
ageal echocardiography had prebypass or postbypass major impact in 13.8% of
cases (n  138/1002). Major impact was more frequent during reoperations (P 
.03). Procedures that benefited most from the additional information were valve
repairs (aortic or atrioventricular) and complex outflow tract reconstructions. Partial
anomalous pulmonary venous connection, tricuspid valve repair (other than of
Ebstein anomaly), simple atrioventricular discordance, aortic arch anomalies, and
secundum atrial septal defects had major impact rates less than 5%. No major
complications occurred. Minor complications occurred in 1% of patients and were
most often observed in infants smaller than 4 kg. Routine use of transesophageal
echocardiography for all patients with congenital heart defects proved cost-effec-
tive.
Conclusions: On the combined basis of the observed rates of major impact, the
minimal complications, and the relative cost advantage, we believe that routine use
of transesophageal echocardiography during most intracardiac repairs of congenital
heart defects is justified, particularly for patients undergoing repeat operations for
congenital cardiac malformations.
Intraoperative transesophageal echocardiography (ITEE) has been used inthe care of patients with congenital heart defects since the late 1980s.Previous reports have suggested that ITEE can provide important additionalinformation during intracardiac repair of congenital heart defects.1-8 Rec-ommendations for the use of ITEE have been broad, in part because of thesmall sample size in previous studies. The preliminary experience with
ITEE during surgery for congenital heart defects at the Mayo Clinic confirmed the
accuracy of ITEE and identified selected patients who would benefit from ITEE on
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the basis of a small study population of 104 patients.9
Bezold and colleagues10 at Texas Children’s Hospital re-
ported a larger experience with ITEE in 341 patients. They
concluded that biplanar imaging was far superior to mono-
planar imaging. ITEE also seemed to be most beneficial for
selected diagnoses and surgical procedures in this series. On
the basis of a study of more than 1500 cases, Stevenson11
concluded that ITEE had a low complication rate (about
3%), but he did not expand on the clinical utility of ITEE in
that recent report.
The largest experience specifically evaluating the utility
of intraoperative echocardiography, involving more than
1000 cases, was published by Ungerleider and associates.12
Their study evaluated both epicardial and transesophageal
echocardiography. Disadvantages of epicardial imaging in-
clude invasion of the surgical field, limited windows, pos-
sible induction of ventricular ectopic beats, and possible
transient hypotension.9 ITEE has therefore become the pre-
ferred modality of imaging during surgery for congenital
heart defects.
Arguments pertaining to the use of ITEE focus on the
cost and the risk of complications related to the procedure
versus the benefit to the patient.13 Ungerleider and associates12
reported, “The average cost for patients who return to the
operating room during their hospitalization for revision of a
repair is significantly greater than for those whose repairs are
revised before they leave the operating room ($94,180.28 
$33,881.63 versus $21,415.79  $8215.74).” Subsequent
cost analysis by Stevenson14 from Seattle focused on a
series of ITEE use in which a 2.8% rate of immediate
surgical revision was found to be cost-effective.
As a continuation of the previous Mayo experience with
ITEE, we are reporting this series involving only biplanar or
multiplanar ITEE during surgical repair for congenital heart
defects. This was a collaborative study involving pediatric
cardiovascular surgeons, congenital cardiologists, and anes-
thesiologists. The first objective of this study was to better
define the impact of ITEE in a larger group of patients. The
second objective was to determine specifically the appro-
priate indications for ITEE during surgery for congenital
heart defects.
Methods
Overview
ITEE was performed in 1002 patients during surgery for congen-
ital heart defects at the request of the clinicians involved in each
patient’s care. Impact of ITEE was assigned prospectively, while
the patient was still in the operating suite, by the surgeon and by
the cardiologist who performed the ITEE. Data were initially
recorded by hand and then converted to a computer database.
Subsequent review of medical records was performed at the end of
the study period and before statistical analysis to confirm the initial
assessment of impact, expand on pertinent clinical information,
and detect any late complications. All patients consented to par-
ticipation in the research study, and the protocol was approved by
the Mayo Clinic institutional review board.
Study Design
Biplanar or multiplanar ITEE was performed and interpreted by a
cardiologist at the request of the surgeon for most intracardiac
procedures. Epicardial echocardiograms were excluded from this
study. ITEE was not routinely performed for simple extracardiac
procedures such as pulmonary artery banding, systemic-pulmonary
arterial shunts, or isolated coarctation repairs. All ITEE procedures
were performed with commercially available echocardiographic
systems (Hewlett Packard Sonos 1000-2500; Hewlett-Packard
Company, Palo Alto, Calif; or Acuson XP-10; Acuson Corpora-
tion, Mountain View, Calif). All ITEE probes had either biplanar
or multiplanar capability. Pediatric probes with a tip diameter of 10
mm were usually used in patients weighing less than 15 kg. Adult
ITEE probes with a tip diameter of 12 to 13 mm were used in
patients weighing more than 15 kg.
Impact was defined by the cardiologist and surgeon at the time
of the procedure and was described as one of five distinct impact
categories. The four positive impact categories were prebypass
major impact, prebypass minor impact, postbypass major impact,
and postbypass minor impact. If no new information was revealed
on either the prebypass or the postbypass scan, the fifth category,
no impact, was recorded for that patient.
The first major impact category was defined as unique preby-
pass information obtained by ITEE that altered the planned surgi-
cal procedure. An example would be the identification of an atrial
septal defect (ASD) not previously known to be present in a patient
undergoing a reoperation in which atrial exposure was not planned
(for example, a right ventricle–pulmonary artery conduit replace-
ment). The second major impact category was defined as unique
postbypass information that described clinically significant resid-
ual findings that would not have been found by routine surgical
pressure measurements. To be considered major impact, these
findings required a return to bypass for surgical revision of the
initial repair. An example would be an iatrogenic ventricular septal
defect (VSD) after subaortic resection that required bypass again
for surgical closure. Combined major impact rates refer to the
percentage of patients in a group who had either prebypass or
postbypass major impact. If a patient had impact in both categories
during a single surgical procedure, that patient was counted only
once in the calculation of the combined impact rate.
The first of two minor impact categories was described as new
prebypass information that did not alter the surgical plan but did
refine the diagnosis. An example would be a previously undetected
ASD in a patient with Ebstein anomaly that would have been
visualized by the surgeon during routine inspection of the atrium
before tricuspid valve repair and thus did not change the surgery.
The second minor impact category was new postbypass informa-
tion that did not lead to surgical intervention. An example would
be moderate mitral valve regurgitation after attempted valve repair
in which this result was accepted and not revised.
Statistical Methods
Statistical analysis was performed for each of five categories: (1)
prebypass major impact, (2) postbypass major impact, (3) com-
bined prebypass and postbypass major impact, (4) prebypass minor
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impact, and (5) postbypass minor impact. The four parameters
used for analysis within each category were age, surgical history
(first operation vs reoperation), primary diagnosis, and surgical
procedure performed. In analyzing surgical history, only the first
operation performed during the study period was included. Statis-
tical analysis included the use of logistic regression models in
establishing associations between echocardiographic benefits and
patient characteristics. Generalized estimating equations were used
within these logistic regression models.15 This made it possible to
use data from patients who had more than one operation by
accounting for within-patient correlations. It was computationally
impossible to evaluate two of the variables of interest—diagnosis
and surgical plan—with generalized estimating equations because
of the large number of diagnostic and surgical categories and the
sparseness of observations in several of the categories. For these
variables, the significance of their association with the benefit
questions was assessed with the Fisher exact test.
Cost Analysis
Cost analysis was performed by comparing the 1999 charges for
the 1002 ITEEs with the cost saving of avoiding late reoperations
in the postbypass major impact cases. No attempt was made to
assign a monetary value to the prebypass information supplied by
ITEE. Four of the 56 patients required bypass again because of
regional wall motion abnormalities caused by air in the coronary
arteries. Ventricular function for these patients improved after this
second bypass without surgical revision. Because no additional
surgery was performed, these 4 patients were excluded from the
total reoperation cost analysis.
Total estimated hospital charges for reoperation in the patients
with postbypass major impact were calculated with the assumption
that the reoperation occurred during the same hospitalization as the
initial surgery. All monetary figures were based on 1999 charges.
According to the surgical indication for revision of the initial
operation, a surgical base charge was established for each patient.
The total time in the operating room for the hypothetic late
reoperation was assumed to be 4 hours (to calculate the incremen-
tal operating room charges). The charge for cardiovascular anes-
thesia with standard supplies was based on the average cost for 20
patients with similar diagnoses.
Each patient undergoing late reoperation was assumed to re-
quire 3 additional days in the intensive care unit. A charge for one
transthoracic echocardiogram was added to the operating room and
intensive care charges to derive the total estimated cost for a late
reoperation. Charges for consulting medical services, laboratory
and radiology tests, and additional days in the hospital but not in
the intensive care unit were not included in the cost analysis
because of the high variability for each individual patient.
Our analysis compared the total estimated cost of late reopera-
tion in the 52 patients with postbypass major impact with 1999
charges for 1002 ITEE studies in patients with congenital heart
defects. The cost for the ITEE included the equipment charge,
prebypass and postbypass pediatric cardiology interpretation, and
the charge for probe insertion.
Results
Data from a total of 1002 patients were analyzed. There was
no significant gender predilection, with 475 female (47.4%)
and 527 male (52.6%) patients. The median age was 9.9
years, with a wide age range from the neonatal period
through late adulthood (2 days to 85 years). The mean age
was 16.7 years. The median weight was 28.2 kg (range
2.3-149 kg). The median height was 134 cm (range 33-196
cm). No statistical difference was present between male and
female patients with regard to height and weight according
to the Wilcoxon rank sum test.
Major Impact
The combined major impact rate for the series was 13.8%
(n  138/1002). Separate rates of preoperative and postop-
erative major impact were 9.1% (n  91/1002) and 5.6%
(n 56/1002), respectively. Findings associated with major
impact are summarized in Tables 1 and 2.
TABLE 1. Findings associated with preoperative major im-
pact
No.
Undetected residual shunts 22
ASD 12
VSD 3
Patent ductus arteriosus 4
Other 3
Influenced atrioventricular valve repair or replacement 20
Influenced ventricular outflow tract enlargement 14
Left 9
Right 5
Undetected obstructive atrial membranes 5
Undetected restrictive ASDs in univentricular heart 5
Undetected pulmonary artery stenoses 4
Undetected anomalous pulmonary veins 3
Undetected anomalous systemic veins 3
Other 15
TABLE 2. Findings associated with postoperative major
impact
No.
Residual shunts 14
VSD 7
ASD 2
Other 5
Valvular dysfunction after repair 11
Redirect intracardiac baffle 9
Intra-atrial 5
Intraventricular 4
Atrioventricular valve dysfunction after surgery other
than atrioventricular valve repair
5
Residual outflow tract stenosis 4
Left ventricle 2
Right ventricle 2
Ventricular dysfunction (intracardiac/vascular air) 4
Fontan pathway stenosis 3
Other 6
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Predictors of Major Impact
Age. The patients were divided into three age groups:
those younger than 6 years, those from 6 to 18 years old,
and adults (18 years old; Table 3). The combined major
impact rate was 15.4% when the patient’s age was younger
than 18 years. The combined major impact rate of 11% in
patients older than 18 years was slightly less than this
(Table 3). As a result, younger age was statistically signif-
icant as a predictor of major impact, with a P value of .018.
Operative history. A total of 920 of the 1002 procedures
were included in the analysis of surgical history. The other
82 procedures were performed on patients who had under-
gone a surgical procedure performed earlier in this series
and were therefore excluded to avoid bias.
Forty-six percent of patients had no previous history of
cardiac surgery and 54% had a history of at least one
previous intracardiac or extracardiac operation. Table 2
describes the rates of major impact observed according to
surgical history. Patients with previous cardiac surgery had
a higher incidence of combined major impact than did those
patients with no previous surgery (16.1% vs 11.3%, P 
.028). According to generalized estimating equations logis-
tic regression models, the odds of having major impact from
either the prebypass or the postbypass scan in the combined
category were 1.52 times higher for patients with previous
surgery than for those undergoing their first cardiac proce-
dure. Patients with previous cardiac surgery also had a
greater incidence of prebypass major impact (10.9% vs
6.7%, P  .026). Rates of postbypass major impact were
similar in the two groups (Table 4).
Primary diagnosis. All 1002 patients were divided into
1 of 22 primary diagnostic categories (Table 5). The largest
categories were univentricular heart (representing 17.8% of
the study group), pulmonary atresia with a VSD or truncus
arteriosus (representing 13.8%), and Ebstein anomaly (rep-
resenting 11.9%).
Of the 22 primary diagnostic categories analyzed, com-
plex right ventricular outflow tract obstruction, defined as
lesions requiring more than a valvotomy or transannular
patch, had the highest combined impact rate (48%; Table 6).
This group of patients was 6 times more likely than the
overall average to have impact. Other diagnostic categories
with high rates of impact were double-outlet right ventricle,
transposition of the great arteries (with or without a VSD),
complex atrioventricular discordance (associated with pul-
monary valve stenosis or atresia and VSD), subaortic ste-
nosis, and partial atrioventricular canal. Impact frequency
ranged from 20% to 31% in these groups. The odds ratios
ranged from 1.6 to 2.9 for these last five groups.
Surgical plan. All patients were divided into 1 of 22
primary surgical categories according to the primary
planned procedure (Table 7). The three most common sur-
gical procedure categories were tricuspid valve repair or
replacement for Ebstein anomaly (11.4%, n  114), VSD
closure combined with right ventricular outflow tract repair
(10.5%, n  105), and the modified Fontan procedure for
single-ventricle physiology (9.8%, n  98).
Of the 22 surgical categories analyzed, the Rastelli pro-
cedure and complex right ventricular outflow tract obstruc-
tions had the highest rates of combined major impact. These
two surgical categories were about 5 times more likely to
have impact (Table 8). Other surgical categories with high
rates of major impact were complete atrioventricular canal,
aortic valve repair, and subaortic stenosis or left ventricular
outflow tract repair. Combined major impact frequencies
ranged from 20% to 24% in these groups. The odds ratio
ranged from 1.6 to 2.0 for these three categories. Each of the
groups can be described as malformations requiring repair
of aortic or atrioventricular valves or complex outflow tract
reconstructions.
Low Rates of Major Impact
The following five categories had combined major impact
rates less than 5%: (1) partial anomalous pulmonary venous
connection, (2) tricuspid valve repair (other than for Ebstein
anomaly), (3) simple atrioventricular discordance, (4) aortic
arch anomalies, and (5) secundum ASD. Only secundum
ASD had a statistically significant lower than average im-
pact rate (P  .01). Although no impact was recorded for
secundum ASD as the primary diagnosis or primary surgical
plan, 2 patients classified in other primary categories re-
quired bypass again for revision of secundum ASD repairs.
The first patient was a 4-month-old infant with Down syn-
drome, a large VSD, and a large secundum ASD. The suture
TABLE 3. Major impact by age (either before or after
bypass)
Age (y) Total patients
Major impact
No. %
6 377 59 15.6
6 to 18 289 44 15.2
18 336 37 11.0*
*P  .018 versus patients younger than 18 years at the time of the
operation.
TABLE 4. Major impact by operative history (either before
or after bypass)
Before bypass (%) After bypass (%) Combined (%)
All patients 8.9 5.6 13.8
First operation 6.7 4.8 11.3
Reoperation 10.9* 6.5† 16.1‡
*P  .026 versus those undergoing their first cardiac operation.
†P not significant versus those undergoing their first cardiac operation.
‡P  .033 versus those undergoing their first cardiac operation.
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closure of the ASD caused mitral valve distortion and
significant mitral valve regurgitation. Because no surgery
had been performed on the mitral valve, routine pressure
measurements of the left atrium were not performed. The
patient was returned to bypass for revision of the ASD
closure (converted to a patch), which relieved the mitral
distortion. The second patient was a 3-year-old with pul-
monary valve stenosis and a patent ductus arteriosus who
also had an ASD and underwent surgical repair of all three
defects. A pericardial patch was used to close the ASD.
After cardiopulmonary bypass, the patient had reduced ox-
ygen saturation. This was presumed to be due to ventilation
problems. ITEE revealed that the pericardial patch had been
attached to the eustachian valve, creating an inferior vena
cava–left atrial shunt. The patient was returned to bypass,
and the atrial patch was revised.
Minor Impact
Overall, the minor impact rate for the pre-bypass ITEE was
12.3% (n 123/1002) and that for the postbypass ITEE was
10% (n  100/1002). A slightly higher prebypass minor
impact rate was observed in the reoperation group (13.7%
vs 10.6%). However, neither age nor operative status was
statistically significant as a predictor of minor impact.
Complications
Complications were reported by the cardiologist, surgeon,
and anesthesiologist. No major complications, defined as
death, esophageal or gastric perforations, accidental extu-
bations, upper gastrointestinal bleeding, or endocarditis,
occurred as a result of ITEE during the study period. Minor
complications, defined as transient airway compression,
problems with ventilation, or compression of the descend-
ing aorta by the probe, were observed in 10 patients, or 1%
of the study population. Minor complications were most
common in patients weighing less than 4 kg. ITEE was
performed in 51 patients weighing less than 4 kg. Minor
complications occurred in 6 of these infants, representing a
minor complication rate of 11.8% in this subset of patients.
Cost Analysis
Fifty-two patients had revision of their initial surgical repair
before leaving the operating room on the basis of ITEE
findings. The total estimated cost for these 52 late reopera-
tions (performed at a later time during the same hospital
stay) would have been $895,664, or $15,994 per operation.
Reoperation costs included charges for the procedure per-
formed, incremental operating room fees, anesthesia and
supplies, 3 nights in the intensive care unit, and one trans-
thoracic echocardiogram. The total 1999 charges for 1002
ITEE studies would have been $746,490, or $745 per ITEE.
Thus this model predicts that ITEE produced an overall
saving of $149,174 by avoiding the costs of late reoperation
in this patient group. These data suggest that if ITEE
prompted an immediate surgical revision in 5% of patients
studied, the ITEE service would pay for itself, even without
considering any benefits derived from the preoperative scan.
Discussion
The use of ITEE in our study population yielded valuable
new information in 13.8% of cases, either changing the
preoperative surgical plan (9.1%) or prompting immediate
revision of hemodynamically significant defects (5.6%).
Patients who benefited the most from ITEE were those
undergoing reoperations of any kind and those in diagnostic
and surgical categories involving valve repair (aortic or
atrioventricular) or complex ventricular outflow tract recon-
TABLE 5. Primary diagnoses
Diagnosis No. of patients
Univentricular heart 178
Pulmonary atresia, VSD, and truncus arteriosus 138
Ebstein anomaly 119
ASD 66
Tetralogy of Fallot 58
Subaortic stenosis 57
Partial atrioventricular canal 55
Complete atrioventricular canal 44
Transposition of the great arteries with or without
VSD
44
Aortic stenosis or regurgitation 34
Complex atrioventricular discordance 33
Double-outlet right ventricle 29
Complex VSD 28
Complex right ventricular outflow tract obstruction 23
Simple VSD 22
Partial anomalous pulmonary venous connection
with an ASD
18
Tricuspid atresia 17
Partial anomalous pulmonary venous connection
with no ASD
11
Simple atrioventricular discordance 7
Total anomalous pulmonary venous connection 4
Aortic arch anomalies 4
Other 13
TABLE 6. Major impact by primary diagnosis (either before
or after bypass)
Primary diagnosis Patients (No.) Impact (%) Odds ratio
Complex right ventricular
outflow tract obstruction
23 47.8 6.040
Double-outlet right ventricle 29 31.0 2.892
Transposition of the great
arteries with or without VSD
44 27.3 2.432
Complex atrioventricular
discordance
33 24.2 2.029
Subaortic stenosis 57 21.1 1.702
Partial atrioventricular canal 55 20.0 1.585
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structions. We therefore strongly recommend the routine
use of ITEE for all such patients during intracardiac
operations.
Although relatively low impact rates were observed for
some diagnostic categories (partial anomalous pulmonary
venous connection, tricuspid valve repair other than for
Ebstein anomaly, simple atrioventricular discordance, aortic
arch anomalies, and secundum ASDs), instances of major
impact did occur among these patients. One could reason-
ably ask whether the routine use of ITEE is truly indicated
for these low-impact categories. In our study population, no
major complications occurred. Only 1% of patients had
minor complications, which occurred primarily in neonates
weighing less than 4 kg. As technology continues to ad-
vance, the introduction of smaller ITEE probes should min-
imize such minor complications in the future. Previous
studies also support the conclusion that ITEE in pediatric
and adult patients is a safe procedure.16-18 Therefore the low
risk of complications does not detract from considering
routine use of ITEE.
If adequate medical resources are available, then the final
question involves the cost-benefit profile of routine use of
ITEE for all patients with congenital heart defects. Steven-
son14 reported a series of operations with ITEE in which a
2.8% rate of immediate surgical revision was found to be
cost-effective. The total cost for reoperation in 11 patients
was $418,447, or $38,040 per operation. The total cost of
performing 400 ITEEs was $259,670, or $650 per ITEE.
Thus in this particular patient group the overall savings
were $158,777.14 One may therefore extrapolate from these
data that the break-even point is a postbypass major impact
rate of 1.8% (n  7/400). The cost analysis performed for
our patient population also supports the conclusion that
ITEE is cost-effective. We found an immediate revision rate
of 5% to be cost-effective for routine application of ITEE.
The major difference in cost analysis between the two
studies was the charge for reoperation ($38,040 for Steven-
son14 versus $15,994 in our study). Our cost analysis was
based on a minimalist strategy and included only essential
charges for the reoperation. Miscellaneous charges for con-
sulting medical services, laboratory and radiologic tests, and
additional days in the hospital on the ward were not in-
cluded in the cost analysis because of the high variability for
each individual patient.
Although the exact costs of reoperation can be debated,
the data still indicate that routine use of ITEE during sur-
gery for congenital heart defects is cost-effective. It is
important to note that this conclusion is based only on
postoperative major impact. There are clearly additional
benefits derived from ITEE, including new information
acquired on the preoperative scans that may lead to changes
in the planned surgery. The preoperative benefits of ITEE
are difficult to quantitate. Preoperative impact would cer-
tainly be reduced if all or most patients had transesophageal
echocardiography as part of their outpatient evaluation. We
believe that this approach is usually unnecessary. Instead,
we have reserved outpatient transesophageal echocardio-
graphic evaluation for those situations in which there is a
question of whether to proceed to surgery. When a patient
clearly needs an operation on the basis of routine evalua-
tions, we prefer to perform ITEE in the operating room.
This is true even if there are some questions that have not
been completely addressed by the preceding evaluation.
ITEE allows both the cardiologist and the surgeon to be
present during the evaluation and to review the data together
before formulating a final surgical plan. We recognize that
this preference has probably influenced the frequency with
TABLE 7. Surgical plan
Plan No. of patients
Ebstein anomaly 114
VSD and right ventricular outflow tract repair 105
Fontan procedure 98
Palliation of univentricular heart 90
Secundum ASD 67
Subaortic and left ventricular outflow tract repair 66
Mitral valve repair 59
Aortic valve repair 58
Complex conduit 54
Simple conduit 46
Partial atrioventricular canal 37
VSD, other 34
Complex right ventricular outflow tract obstruction 26
Complete atrioventricular canal 25
Rastelli procedure 23
VSD, membranous 22
Other 26
Partial anomalous pulmonary venous connection
with ASD
18
Arterial switch 15
Partial anomalous pulmonary venous connection
with no ASD
10
Tricuspid repair (not Ebstein) 5
Total anomalous pulmonary venous connection 4
TABLE 8. Major impact by surgical plan (either before or
after bypass)
Surgical plan
Patients
(No.)
Impact
(%)
Odds
ratio
Rastelli procedure 23 43.5 5.024
Complex right ventricular outflow
tract obstruction
26 42.3 4.815
Complete atrioventricular canal 25 24.0 1.987
Aortic valve repair 58 20.7 1.663
Subaortic and left ventricular
outflow tract repair
66 19.7 1.562
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which ITEE was found to have major preoperative impact in
our series. However, we believe that this approach is the
most efficient method, particularly for pediatric patients,
who would generally require an additional general anes-
thetic if transesophageal echocardiography were performed
outside the operating room.
Limitations of the Study
Because of the referral pattern at the Mayo Clinic, our study
population has a larger proportion of adults with congenital
heart defects than most previous reports. In addition, ITEE
was not performed during all neonatal intracardiac proce-
dures. For example, repair of total anomalous pulmonary
venous connections frequently was not evaluated with ITEE
because the probe would possibly compromise surgical
exposure in the posterior mediastinum. Also, in some cases
ITEE was not requested if the weight of the neonate was so
low that ventilation problems could occur. Therefore our
conclusions may not be easily generalized to a broad neo-
natal population. However, they should apply to the vast
majority of patients requiring repair of congenital heart
defects, namely those weighing more than 4 kg.
Conclusions
Major impact was observed in almost all diagnostic and
surgical categories and was more common among patients
who had previous cardiac surgery. There were no major
complications, and minor complications were rare. Even
though some diagnostic and surgical groups had relatively
low rates of major impact, observed overall frequencies of
major impact and immediate revision support the premise
that routine use of ITEE would be cost-effective. We there-
fore believe that routine use of ITEE during intracardiac
surgery for all congenital heart defects is justified.
We thank Christine M. Lohse from the Section of Biostatistics
at the Mayo Clinic for her statistical support.
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